Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials

Published:2016-08-15 Issue:12 Volume:18 Page:1199-1206
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Tang H. L.¹²³,Li D. D.⁴,Zhang J. J.⁵,Hsu Y. H.⁶,Wang T. S.⁷,Zhai S. D.¹,Song Y. Q.²³

Affiliation:

1. Department of Pharmacy; Peking University Third Hospital; Beijing China

2. Department of Epidemiology, Richard M. Fairbanks School of Public Health; Indiana University; Indianapolis USA

3. Center for Pharmacoepidemiology, Richard M. Fairbanks School of Public Health; Indiana University; Indianapolis USA

4. Department of Pharmacy; Beijing Friendship Hospital, Capital Medical University; Beijing China

5. Division of Nephrology; Sidney Kimmel Medical College at Thomas Jefferson University; Philadelphia Pennsylvania USA

6. Hebrew Seniorlife Institute for Aging Research and Harvard Medical School; Boston Massachusetts USA

7. Department of Pharmacy Administration and Clinical Pharmacy; Peking University Health Science Center; Beijing China

Funder

Indiana University Health-Indiana University School of Medicine Strategic Research Initiative

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12742/fullpdf

Reference37 articles.

1. The impact of diabetes and diabetes medications on bone health;Gilbert;Endocr Rev,2015

2. Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care;Rathmann;J Diabetes Complications,2015

3. Type 2 diabetes and the skeleton: new insights into sweet bones;Shanbhogue;Lancet Diabetes Endocrinol,2016

4. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis;Loke;Can Med Assoc J,2009

5. Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: clinical data and mechanism of action;Fujita;J Diabetes Invest,2014

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives;World Journal of Cardiology;2024-05-26

2. Bone Health in Patients With Type 2 Diabetes;Journal of the Endocrine Society;2024-05-23

3. Bone metabolism in diabetes: a clinician’s guide to understanding the bone–glucose interplay;Diabetologia;2024-05-18

4. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

5. Mechanism of traditional Chinese medicine in elderly diabetes mellitus and a systematic review of its clinical application;Frontiers in Pharmacology;2024-03-06